{"id":57681,"date":"2023-07-01T07:04:11","date_gmt":"2023-07-01T05:04:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/"},"modified":"2023-07-01T07:04:11","modified_gmt":"2023-07-01T05:04:11","slug":"fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/","title":{"rendered":"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. – FATE"},"content":{"rendered":"
\n

NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into Fate Therapeutics, Inc. (NasdaqGM: FATE).<\/p>\n

<\/a>
<\/a><\/p>\n

\nOn April 2, 2020, the Company announced its entry into a global collaboration and option agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for cell-based cancer immunotherapies, under which Fate received a $50 million upfront payment and was eligible for up to $3 billion in various milestone payments and double-digit royalties on any net sales from the collaboration. Then, on January 5, 2023, the Company disclosed that it had terminated the Janssen Agreement and that all licenses and other rights granted pursuant to the Agreement would terminate, that it would reduce its headcount to about 220 employees in Q1 2023, and that it would discontinue several of its natural cell killer programs in various cancers.<\/p>\n

\nThereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws, which remains pending.<\/p>\n

\nKSF\u2019s investigation is focusing on whether Fate\u2019s officers and\/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.<\/p>\n

\nIf you have information that would assist KSF in its investigation, or have been a long-term holder of Fate Therapeutics shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com<\/a>), or visit https:\/\/www.ksfcounsel.com\/cases\/nasdaqgm-fate\/<\/a> to learn more.<\/p>\n

\nAbout Kahn Swick & Foti, LLC<\/p>\n

\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\u2019s premier boutique securities litigation law firms. KSF serves a variety of clients \u2013 including public institutional investors, hedge funds, money managers and retail investors \u2013 in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.<\/p>\n

\nTo learn more about KSF, you may visit ksfcounsel.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nKahn Swick & Foti, LLC
\n
Lewis Kahn, Managing Partner
\n
lewis.kahn@ksfcounsel.com<\/a>
1-877-515-1850<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into Fate Therapeutics, Inc. (NasdaqGM: FATE). On April 2, 2020, the Company announced its entry into a global collaboration and option agreement with … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57681","6":"format-standard","7":"category-industry"},"yoast_head":"\nFATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. - FATE - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. - FATE - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into Fate Therapeutics, Inc. (NasdaqGM: FATE). On April 2, 2020, the Company announced its entry into a global collaboration and option agreement with ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-01T05:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230630496489\/en\/1510725\/21\/Latest_KSF_SEC.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. – FATE\",\"datePublished\":\"2023-07-01T05:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/\"},\"wordCount\":409,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230630496489\\\/en\\\/1510725\\\/21\\\/Latest_KSF_SEC.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/\",\"name\":\"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. - FATE - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230630496489\\\/en\\\/1510725\\\/21\\\/Latest_KSF_SEC.jpg\",\"datePublished\":\"2023-07-01T05:04:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230630496489\\\/en\\\/1510725\\\/21\\\/Latest_KSF_SEC.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230630496489\\\/en\\\/1510725\\\/21\\\/Latest_KSF_SEC.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. – FATE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. - FATE - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/","og_locale":"en_US","og_type":"article","og_title":"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. - FATE - Pharma Trend","og_description":"NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\u201cKSF\u201d), announces that KSF has commenced an investigation into Fate Therapeutics, Inc. (NasdaqGM: FATE). On April 2, 2020, the Company announced its entry into a global collaboration and option agreement with ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/","og_site_name":"Pharma Trend","article_published_time":"2023-07-01T05:04:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230630496489\/en\/1510725\/21\/Latest_KSF_SEC.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. – FATE","datePublished":"2023-07-01T05:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/"},"wordCount":409,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230630496489\/en\/1510725\/21\/Latest_KSF_SEC.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/","url":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/","name":"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. - FATE - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230630496489\/en\/1510725\/21\/Latest_KSF_SEC.jpg","datePublished":"2023-07-01T05:04:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230630496489\/en\/1510725\/21\/Latest_KSF_SEC.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230630496489\/en\/1510725\/21\/Latest_KSF_SEC.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/fate-therapeutics-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-fate-therapeutics-inc-fate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. – FATE"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57681"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57681\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}